President Trump has nominated Alex Azar as head of the Department of Health and Human Services. Trump tweeted the nomination Monday morning: “Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices!”
Azar left the pharmaceutical company Eli Lilly in January after working there for nearly a decade, most recently serving as the president of Lilly USA. He now runs a consulting firm, according to his LinkedIn profile. Working in HHS during President George W. Bush's administration, he served as the department’s general counsel from 2001 to 2005 and then assumed the role of deputy secretary for the next two years.
The nomination process, however, is likely to difficult, according to The Hill, which noted, “Democrats will put up a fight against any potential secretary who supports key items of the Republican agenda, such as repealing and replacing ObamaCare. But,” the article continues, “the GOP controls 52 seats, and Azar only needs 51 votes to win Senate confirmation.
Read more about Azar and the nomination at The Hill.
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer
